𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus

✍ Scribed by T. Sitter; M. Spannagl; H. Schiffl

Publisher
Springer
Year
1992
Tongue
English
Weight
427 KB
Volume
65
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-annexin V antibody in systemic lupu
Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
✍ Dr. Juzo Matsuda; Noriko Saitoh; Kengo Gohchi; Moritaka Gotoh; And Miyo Tsukamot πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## Abstract We investigated anti‐annexin V antibody (aANX) in patients with systemic lupus erythe‐matosus (SLE), and correlated to positivity with lupus anticoagulant (LA)/anticardiolipin antibody (aCL). aANX was positive in 12/47 SLE patients (26%), including 7 with Ξ²~2~‐glycoprotein 1 (GPl)‐depen

Natural antibodies in sera of patients w
Natural antibodies in sera of patients with systemic lupus erythematosus
✍ Ferid Ben Fadhel; B. Guilbert; P. Matsiota; S. Avrameas; Y. Gorgi; K. Ayed πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 383 KB πŸ‘ 2 views

Sera obtained from fifty-five patients with active systemic lupus erythematosus (SLE) and from four patients with mixed connective tissue disease (MCTD) previously shown by immunofluorescence and by double immunodiffusion to possess antinuclear antibodies, were tested for the presence of natural ant

Neurological disease associated with ant
Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features
✍ A. M. Chancellor; R. E. Cull; D. C. Kilpatrick; C. P. Warlow πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 673 KB

Anticardiolipin antibodies (aCL), one of a group of antiphospholipid antibodies which include the lupus anticoagulant (LA), may occur in association with systemic lupus erythematosus (SLE) and are less commonly detected in other diseases. We retrospectively reviewed the clinical and immunological fe